Y. Ishibashi et al., THE NITRIC-OXIDE DONOR ITF-1129 AUGMENTS SUBENDOCARDIAL BLOOD-FLOW DURING EXERCISE-INDUCED MYOCARDIAL-ISCHEMIA, Journal of cardiovascular pharmacology, 30(3), 1997, pp. 374-382
The effect of the nitric oxide donor ITF 1129 and nitroglycerin (NTG)
on myocardial blood flow was examined in dogs with a Doppler velocity
probe, hydraulic occluder, and indwelling microcatheter in the left an
terior descending coronary artery (LAD). Studies were performed during
treadmill exercise in the presence of a coronary artery stenosis. The
effects of ITF 1129 in doses of 3 and 10 mu g/kg/min i.v. were compar
ed with NTG (2 mu g/kg/min i.v.). Neither ITF 1129 nor NTG caused sign
ificant alteration of heart rate, arterial blood pressure, or left ven
tricular systolic pressure. During partial inflation of the occluder t
o decrease distal coronary pressure to 55 +/- 2 mm Hg, mean myocardial
blood flow measured with microspheres was 0.72 +/- 0.14 ml/min/g in t
he region perfused by the stenotic coronary artery compared with 2.93
+/- 0.40 ml/min/g in a normally perfused control region. With no chang
e in distal coronary pressure, ITF 1129 increased mean myocardial bloo
d flow in the stenosis perfused region to 1.15 +/- 0.24 ml/min/g (3 mu
g/kg/min i.v.) and to 1.20 +/- 0.28 ml/min/g (10 mu g/kg/min i.v.), w
hereas NTG (2 mu g/kg/min iv) increased blood flow to 1.16 +/- 0.22 ml
/min/g (each p < 0.05). The increase in myocardial blood flow produced
by ITF 1129 or NTG occurred principally in the deeper myocardial lave
rs with no change in subepicardial flow. As a result, the subendocardi
al/subepicardial blood flow ratio (ENDO/EPI) increased from 0.44 +/- 0
.09 during control stenosis to 0.85 +/- 0.13 after ITF 1129 (10 mu g/k
g/min i.v.) and to 0.81 +/- 0.12 after NTG. Neither ITF 1129 nor NTG s
ignificantly altered myocardial blood flow in the normally perfused co
ntrol region. The effect of ITF 1129 and NTG on myocardial perfusion o
ccurred without alterations of distal coronary pressure or left ventri
cular diastolic pressure, indicating a primary effect on the intramura
l coronary microvasculature.